Copyright
©The Author(s) 2020.
World J Gastrointest Surg. Dec 27, 2020; 12(12): 555-563
Published online Dec 27, 2020. doi: 10.4240/wjgs.v12.i12.555
Published online Dec 27, 2020. doi: 10.4240/wjgs.v12.i12.555
Figure 4 Postoperative specimens and pathologies.
A: Left 3rd rib metastasis; B: Pathology of metastasis, with complete regression and no metastatic tumor left (tumor regression grade classification: 0, × 100); C: Gastric cancer; D: Pathology of ulcerative gastric moderately differentiated adenocarcinoma that infiltrated into the submucosa and adjacent to the superficial muscle layer locally, low-grade intraepithelial neoplasia of some glands in the surrounding mucosa, and tumor stroma infiltrated with a small amount of inflammatory cells, with 1/36 lymph node metastasis (partial response, tumor regression grade classification: 2, × 100). Immunohistochemistry revealed CD34(+), blood vessels(+), CDX2(+), CgA(-), CK20(-), CK7(+), CKpan(+), CyclinD1(+), EGFR(+), Ki-67 (+75%), P53(+), Survivin(+), Syn(-), CerbB-2(2+), MLH1(+), MSH2(+), MSH6(+), and PMS2(+).
- Citation: Zhang Y, Zhang ZX, Lu ZX, Liu F, Hu GY, Tao F, Ye MF. Individualized treatment for gastric cancer with rib metastasis: A case report. World J Gastrointest Surg 2020; 12(12): 555-563
- URL: https://www.wjgnet.com/1948-9366/full/v12/i12/555.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v12.i12.555